Xinghua Sui - Sun Yat Sen Univ, Dept Ecol, State Key Lab Biocontrol, Guangzhou, Peoples R China

基本信息

浏览量：4

职业迁徙

个人简介

Xinghua Sui currently works at the School of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University. Xinghua does research in Bioinformatics, Mathematical Oncology and Drug Design.

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Fish Oil-Based Microemulsion Can Efficiently Deliver Oral Peptide Blocking PD-1/PD-L1 and Simultaneously Induce Ferroptosis for Cancer Immunotherapy

Xin Yang,Wanqiong Li,Shuzhen Li,Shaomeng Chen,Zheng Hu,Zhuoying He,Xueqin Zhu,Xiaoshuang Niu,Xiuman Zhou,Huihao Li,Youmei Xiao,Juan Liu,Xinghua Sui,Guanyu Chen,Yanfeng Gao

JOURNAL OF CONTROLLED RELEASE (2024): 654-667

引用0浏览0WOS引用

An Integrated Framework for Prognosis Prediction and Drug Response Modeling in Colorectal Liver Metastasis Drug Discovery

Xiuman Zhou,Yuzhen Qian,Chen Ling,Zhuoying He,Peishang Shi,Yanfeng Gao,Xinghua Sui

JOURNAL OF TRANSLATIONAL MEDICINE（2024）

引用0浏览0WOS引用

"新医科"背景下的生物技术制药课程教学改革的探索

刘娟, 吕妍蓉,周焕彬,隋兴华, 陈红波

The Guide of Science & Education (2023)

引用0浏览0引用

Peptide Drugs:A New Direction in Cancer Immunotherapy

Xinghua Sui,Xiaoshuang Niu,Xiuman Zhou,Yanfeng Gao

Cancer biology & medicineno. 3 (2023)

引用0浏览0WOS引用

Integrative Analysis of Bulk and Single-Cell Gene Expression Profiles to Identify Tumor-Associated Macrophage-Derived CCL18 As a Therapeutic Target of Esophageal Squamous Cell Carcinoma

Xinghua Sui,Chunxia Chen,Xiuman Zhou,Xueyan Wen,Chao Shi,Guanyu Chen,Juan Liu,Zhuoying He,Yongjie Yao,Yin Li,Yanfeng Gao

Journal of experimental & clinical cancer research（2023）

引用2浏览0WOS引用

Development of a novel peptide targeting GPR81 to suppress adipocyte-mediated tumor progression

Shaomeng Chen,Xiuman Zhou,Wanqiong Li,Xin Yang,Xiaoshuang Niu,Zheng Hu,Shuzhen Li,Guanyu Chen,Xinghua Sui,Juan Liu,Yanfeng Gao

Biochemical pharmacology（2023）

引用0浏览0WOS引用

Discovery of a Novel Dual-Targeting D-peptide to Block CD24/Siglec-10 and PD-1/PD-L1 Interaction and Synergize with Radiotherapy for Cancer Immunotherapy

Wenhui Shen,Peishang Shi,Qingyu Dong,Xiuman Zhou,Chunxia Chen,Xinghua Sui, Wentong Tian,Xueqin Zhu,Xiaoxi Wang,Shengzhe Jin,Yahong Wu,Guanyu Chen,Lu Qiu,Wenjie Zhai,Yanfeng Gao

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2023）

引用3浏览0WOS引用

Design of a Novel Chimeric Peptide Via Dual Blockade of CD47/SIRPα and PD-1/PD-L1 for Cancer Immunotherapy

Zheng Hu,Wanqiong Li,Shaomeng Chen,Danhong Chen,Ran Xu,Danlu Zheng,Xin Yang,Shuzhen Li,Xiuman Zhou,Xiaoshuang Niu,Youmei Xiao,Zhuoying He,Huihao Li,Juan Liu,Xinghua Sui,Yanfeng Gao

Science China Life Sciences（2023）

引用3浏览0WOS引用

Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response

Chen Ling,Xiuman Zhou,Yanfeng Gao,Xinghua Sui

Pharmaceuticalsno. 5 (2022): 605-605

引用0浏览0WOS引用

Relative Importance of Ecological, Evolutionary and Anthropogenic Pressures on Extinction Risk in Chinese Angiosperm Genera

Haibin Yu,Xinghua Sui,Miao Sun,Xue Yin,David C. Deane

FRONTIERS IN ECOLOGY AND EVOLUTION (2022)

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn